Founded in 2011

HIC specializes in the creation of innovative technologies. The company is recognized fort its innovative breath analysis solutions, especially in non-communicable diseases (NCDs) such as emergent diseases, Covid-19.

After 12 years of intensive research, HIC's hallmark product is the Breath NCDs Analyzer. The device analyzes NCDs-related biomarkers in a patient's breath and provides accurate, real-time results without invasive procedures or specialized training.

In addition, HIC has contributed to the fight against Covid-19 by devising a breath analyzer capable of detecting Covid-19 biomarkers in a patient's breath, thereby providing a rapid and 

accurate diagnostic tool for the disease.